![Holger Wesche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Holger Wesche
Chief Tech/Sci/R&D Officer at
HARPOON THERAPEUTICS, INC.
Profile
Holger Wesche is currently the Chief Scientific Officer at Harpoon Therapeutics, Inc. He previously worked as a Scientific Director at Amgen, Inc. from 2013 to 2015.
He obtained a doctorate degree from the University of Hannover.
Holger Wesche active positions
| Companies | Position | Start |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/09/2018 |
Former positions of Holger Wesche
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 31/03/2015 |
Training of Holger Wesche
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Hannover
 University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
- Stock Market
- Insiders
- Holger Wesche
